|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2007-8-16
|
|
pubmed:abstractText |
Episodic infliximab (IFX) treatment is associated with the formation of antibodies to IFX (ATIs) in the majority of patients, which can lead to infusion reactions and a shorter duration of response. Concomitant use of immunosuppressives (IS) reduces the risk of ATI formation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0017-5749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1226-31
|
|
pubmed:dateRevised |
2010-9-2
|
|
pubmed:meshHeading |
pubmed-meshheading:17229796-Adolescent,
pubmed-meshheading:17229796-Adult,
pubmed-meshheading:17229796-Aged,
pubmed-meshheading:17229796-Antibodies, Monoclonal,
pubmed-meshheading:17229796-Antibody Formation,
pubmed-meshheading:17229796-Azathioprine,
pubmed-meshheading:17229796-Crohn Disease,
pubmed-meshheading:17229796-Drug Administration Schedule,
pubmed-meshheading:17229796-Drug Therapy, Combination,
pubmed-meshheading:17229796-Female,
pubmed-meshheading:17229796-Gastrointestinal Agents,
pubmed-meshheading:17229796-Humans,
pubmed-meshheading:17229796-Immunosuppressive Agents,
pubmed-meshheading:17229796-Infusions, Parenteral,
pubmed-meshheading:17229796-Male,
pubmed-meshheading:17229796-Methotrexate,
pubmed-meshheading:17229796-Middle Aged,
pubmed-meshheading:17229796-Prospective Studies,
pubmed-meshheading:17229796-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease.
|
|
pubmed:affiliation |
Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
